Archives

by in
Entry Author Date Location
Genzyme Boss Henri Termeer Not Ready To Sell to Sanofi, Ride Into the Sunset, Sources Say 09/22/10 Boston
Good Start Genetics Emerges from Stealth with $18M Series A Round 09/10/10 Boston
PacBio Seeks $200M IPO, Complete Genomics Adds $39M, Siluria Envisions Cleaner Plastics, & More Bay Area Life Sciences News 08/20/10 San Francisco
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader 08/17/10 San Francisco
Gilead’s Lung Drug Ace, Bruce Montgomery, Hits Free Agent Market, Scopes Startup Ideas 08/05/10 Seattle
Lucky 13: Xconomy Boston’s Top Stories of 2010 (So Far) 07/23/10 Boston
AlloCure Arrives in New England, Merck Shutters Cambridge Research Site, Infinity Cuts Deal With Intellikine, & More Boston-Area Life Sciences News 07/09/10 Boston
Alnara Pharma Used “Flexible” Strategy on Road to Eli Lilly Deal 07/08/10 Boston
Drug Giant Eli Lilly Buys Alnara Pharma To Get Cystic Fibrosis Drug 07/02/10 Boston
Seattle Genetics’ Dark Horse, Gilead Beats Novartis, Oncothyreon Back in the Saddle, & More Seattle-Area Life Sciences News 06/24/10 Seattle
Gilead CF Drug Passes Trial 06/18/10 San Francisco
FoldRx Pharma Finds $29M, Plans to Seek Approval of First Drug in 2010 06/15/10 Boston
Sequenom Highlights Its Good News, Keeps Lid on Bad 03/15/10 San Diego
Bruce Montgomery Joins Zymo Board 03/11/10 Seattle
Avila Sets Out to Take on Vertex, CombinatoRx Nails FDA Approval, Millipore Opts for Merck KGaA over Thermo Fisher, & More Boston-Area Life Sciences News 03/05/10 Boston
Prominent Flatley Family Launches Boston Nonprofit for Cystic Fibrosis Drug Research 03/03/10 Boston
Gilead Sciences Gets FDA Green Light To Sell Cystic Fibrosis Drug 02/23/10 Seattle
Alnara Bags $35M B Round, Plans to Seek FDA Approval for Cystic Fibrosis Drug 01/28/10 Boston
Vertex’s Matt Emmens on His Journey From Security Guard to CEO 01/27/10 Boston
Gilead Deepens Roots in Seattle, Seeks Long-Term Payoff From Lung Disease Research 01/13/10 Seattle
Gilead Cystic Fibrosis Drug Gets Green Light From FDA Panel 12/10/09 Seattle
Vertex Snags Extra $58M 12/04/09 Boston
Vertex Raises $443M in Yet Another Monster Stock Sale 12/03/09 Boston
Domain Raises a $500M VC Fund, Dissident Prods Amylin Again, Avanir Passes Pivotal Test, & More San Diego Life Sciences News 08/13/09 San Diego
Vertex Drug Could Be “Man on the Moon” for Cystic Fibrosis Therapy, Says Researcher Bonnie Ramsey 08/07/09 National
Cash Running Low at Altus Pharma 08/05/09 Boston
Pulmatrix, With One Drug for Multiple Bugs, Aims to Fundamentally Change Flu Treatment 06/09/09 Boston
Alnara Pharma Completes Key Cystic Fibrosis Drug Trial, “Extremely Encouraged” by Results 05/28/09 Boston
Vertex Starts Pivotal CF Trials 05/27/09 Boston
Obama Stimulates UW, Public Biotechs Run Low on Cash, Healionics Ships Glaucoma Product & More Seattle-Area Life Sciences News 03/26/09 Seattle
Page 3 of 4 « previous page · next page »